Skip to content
healthcare.dev

Levothyroxine Sodium

NDC 25021-470, Levothyroxine Sodium Anhydrous, injection, powder, lyophilized, for solution, from Sagent Pharmaceuticals.

Product NDC
25021-470
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208749
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-470 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM ANHYDROUS500 ug/5mL

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
25021-470-10250210470101 VIAL in 1 CARTON (25021-470-10) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f57e9b19-6f17-4520-80fc-511322cc56c9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-470

Use it

Look up 25021-470 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-470 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-470. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.